Enact is profitable, overcapitalized against PMIERs, and returning cash through dividends and buybacks, but the public-company thesis still runs through mortgage credit, GSE rules, housing affordability, reinsurance markets, and Genworth's 81% control.
The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.
